Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

December 01, 1993; Volume 44,Issue 6
  • You have access
    Close reciprocal regulation of beta 1- and beta 2-adrenergic receptors by dexamethasone in C6 glioma cells: effects on catecholamine responsiveness.
    H Zhong and K P Minneman
    Molecular Pharmacology December 1993, 44 (6) 1085-1093;
  • You have access
    Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
    N Blin, L Camoin, B Maigret and A D Strosberg
    Molecular Pharmacology December 1993, 44 (6) 1094-1104;
  • You have access
    Cycloheximide induces the alpha 1B adrenergic receptor gene by activation of transcription in DDT1 MF-2 smooth muscle cells.
    Z W Hu and B B Hoffman
    Molecular Pharmacology December 1993, 44 (6) 1105-1112;
  • You have access
    Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization.
    D E Frail, A M Manelli, D G Witte, C W Lin, M E Steffey and R G Mackenzie
    Molecular Pharmacology December 1993, 44 (6) 1113-1118;
  • You have access
    Ethanol increases delta-opioid receptor gene expression in neuronal cell lines.
    M E Charness, G Hu, R H Edwards and L A Querimit
    Molecular Pharmacology December 1993, 44 (6) 1119-1127;
  • You have access
    pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin.
    D Siegel, H Beall, M Kasai, H Arai, N W Gibson and D Ross
    Molecular Pharmacology December 1993, 44 (6) 1128-1134;
  • You have access
    Nuclear localization of bacterial Streptoalloteichus hindustanus bleomycin resistance protein in mammalian cells.
    T P Calmels, J S Mistry, S C Watkins, P D Robbins, R McGuire and J S Lazo
    Molecular Pharmacology December 1993, 44 (6) 1135-1141;
  • You have access
    2,3,7,8-tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick embryo hearts.
    L Canga, L Paroli, T J Blanck, R B Silver and A B Rifkind
    Molecular Pharmacology December 1993, 44 (6) 1142-1151;
  • You have access
    Monoclonal antibody AE-2 modulates carbamate and organophosphate inhibition of fetal bovine serum acetylcholinesterase.
    A D Wolfe, P K Chiang, B P Doctor, N Fryar, J P Rhee and M Saeed
    Molecular Pharmacology December 1993, 44 (6) 1152-1157;
  • You have access
    Human m3 muscarinic acetylcholine receptor carboxyl-terminal threonine resides are required for agonist-induced receptor down-regulation.
    J Yang, C D Logsdon, T E Johansen and J A Williams
    Molecular Pharmacology December 1993, 44 (6) 1158-1164;
  • You have access
    Selective irreversible binding of chloroethylclonidine at alpha 1- and alpha 2-adrenoceptor subtypes.
    M C Michel, J Kerker, T A Branchek and C Forray
    Molecular Pharmacology December 1993, 44 (6) 1165-1170;
  • You have access
    Stable allosteric binding of m1-toxin to m1 muscarinic receptors.
    S I Max, J S Liang and L T Potter
    Molecular Pharmacology December 1993, 44 (6) 1171-1175;
  • You have access
    Role of arachidonic acid and glutamate in the formation of inositol phosphates induced by noradrenalin in striatal astrocytes.
    P Marin, N Stella, J Cordier, J Glowinski and J Prémont
    Molecular Pharmacology December 1993, 44 (6) 1176-1184;
  • You have access
    P2U-purinergic receptors on C6-2B rat glioma cells: modulation of cytosolic Ca2+ and cAMP levels by protein kinase C.
    R Munshi, M A DeBernardi and G Brooker
    Molecular Pharmacology December 1993, 44 (6) 1185-1191;
  • You have access
    Chlorocresol: an activator of ryanodine receptor-mediated Ca2+ release.
    F Zorzato, E Scutari, V Tegazzin, E Clementi and S Treves
    Molecular Pharmacology December 1993, 44 (6) 1192-1201;
  • You have access
    Enhancement of recombinant gamma-aminobutyric acid type A receptor currents by chronic activation of cAMP-dependent protein kinase.
    T P Angelotti, M D Uhler and R L Macdonald
    Molecular Pharmacology December 1993, 44 (6) 1202-1210;
  • You have access
    Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors.
    K L Hadingham, P B Wingrove, K A Wafford, C Bain, J A Kemp, K J Palmer, A W Wilson, A S Wilcox, J M Sikela and C I Ragan
    Molecular Pharmacology December 1993, 44 (6) 1211-1218;
  • You have access
    Cycloalkanemethanols discriminate between volume- and length-dependent loss of activity of alkanols at the Torpedo nicotinic acetylcholine receptor.
    S C Wood, W A Hill and K W Miller
    Molecular Pharmacology December 1993, 44 (6) 1219-1226;
  • You have access
    Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
    S Schuldiner, S Steiner-Mordoch, R Yelin, S C Wall and G Rudnick
    Molecular Pharmacology December 1993, 44 (6) 1227-1231;
  • You have access
    New sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies.
    R G Booth, S D Wyrick, R J Baldessarini, N S Kula, A M Myers and R B Mailman
    Molecular Pharmacology December 1993, 44 (6) 1232-1239;
  • You have access
    Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart.
    D Rampe, B Wible, A M Brown and R C Dage
    Molecular Pharmacology December 1993, 44 (6) 1240-1245;
  • You have access
    Molecular mechanism of delta-selectivity of indole analogs of nonpeptide opioids.
    P A Maguire, J J Perez, N F Tsai, L Rodriguez, M F Beatty, H O Villar, J J Kamal, C Upton, A F Casy and G H Loew
    Molecular Pharmacology December 1993, 44 (6) 1246-1251;
  • You have access
    Agonist response kinetics of N-methyl-D-aspartate receptors in neurons cultured from rat cerebral cortex and cerebellum: evidence for receptor heterogeneity.
    T Priestley and J A Kemp
    Molecular Pharmacology December 1993, 44 (6) 1252-1257;
  • You have access
    Phosphorylation of the enantiomers of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinase.
    L L Bennett, W B Parker, P W Allan, L M Rose, Y F Shealy, J A Secrist, J A Montgomery, G Arnett, R L Kirkman and W M Shannon
    Molecular Pharmacology December 1993, 44 (6) 1258-1266;
  • You have access
    Cytochrome P450 2B1-mediated one-electron reduction of adriamycin: a study with rat liver microsomes and purified enzymes.
    A R Goeptar, J M Te Koppele, E K Lamme, J M Piqué and N P Vermeulen
    Molecular Pharmacology December 1993, 44 (6) 1267-1277;
  • You have access
    Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin: 28.
    A M O'Carroll, S J Lolait, M König and L C Mahan
    Molecular Pharmacology December 1993, 44 (6) 1278;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 44, Issue 6
1 Dec 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics